Q3 2010

Filed Nov 19, 2010 · 10-Q · 50 days after period end · 0001469928-10-000124

Q3 2010 · 10-Q

Revenue—

Net Income

-$4.85K

no prior Q3 2009 on file

EPS Diluted

$0.00

no prior Q3 2009 on file

Operating Cash Flowderived-$5,592—

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2010 · filed Nov 19, 2010 · 50 d after period end

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR